
Polynovo ( ($AU:PNV) ) has provided an announcement. PolyNovo Limited disclosed the final director’s interest notice for Christine Emmanuel-Donnelly, who ceased serving as a director on 30 October 2026. She
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CALZF | Polynovo | 0.58 | -0.16 | -21.45% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.58 | -21.45% |

Polynovo ( ($AU:PNV) ) has provided an announcement. PolyNovo Limited disclosed the final director’s interest notice for Christine Emmanuel-Donnelly, who ceased serving as a director on 30 October 2026. She

Polynovo ( ($AU:PNV) ) has issued an announcement. PolyNovo Limited has reported that all resolutions put to shareholders at its 2026 Annual General Meeting were passed by poll, signalling strong

Polynovo ( ($AU:PNV) ) has issued an announcement. In FY26 PolyNovo recorded revenue of $150 million, up 16% on the prior year and roughly 39 times FY17 levels, alongside a

Polynovo ( ($AU:PNV) ) has provided an update. PolyNovo has announced the impending departure of Chief Financial Officer Jan Gielen, who will leave the company after nearly eight years to

Polynovo ( ($AU:PNV) ) has issued an announcement. PolyNovo has called its 2026 Annual General Meeting for 30 October 2026 at 11:00 am AEDT, to be conducted as a hybrid

Polynovo ( ($AU:PNV) ) just unveiled an announcement. PolyNovo has strengthened its board with the appointment of medical technology veterans Dean Phizacklea and Andrew Price as independent non-executive directors, effective

Polynovo ( ($AU:PNV) ) has issued an update. PolyNovo has lodged its corporate governance statement for the financial year ended 30 June 2026, confirming that the document is current as

An announcement from Polynovo ( ($AU:PNV) ) is now available. PolyNovo’s 2026 annual report presents a business built on a proven wound-care platform and positioned to scale for future growth.

Polynovo Limited (($AU:PNV)) has held its Q4 earnings call. Read on for the main highlights of the call. Polynovo’s latest earnings call struck a confident tone, with management emphasizing strong

Polynovo ( ($AU:PNV) ) just unveiled an update. PolyNovo has released a presentation outlining its FY26 results, accompanied by extensive disclaimers clarifying that the material is for general informational purposes
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $387.51M | $0.00 | $55.89M | -1.95 | 79.25 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.